Long‐term prognosis of vaccine‐induced contact allergy to aluminium: Third patch‐test with additional test preparations
Contact Dermatitis · 2023
DOI: 10.1111/cod.14386 ↗Kurz gefasst
Fachartikel in der Zeitschrift Contact Dermatitis, 2023. Verfasst von Anette Gente Lidholm und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology and Venereology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden. Hauptthemen laut MEDLINE: Dermatitis, Allergic Contact, Pertussis Vaccine. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: ALF-Agreement.
Abstract (Originalsprache)
Background
A high incidence of local itching subcutaneous nodules and aluminium allergy was observed in clinical trials of a new aluminium adsorbed pertussis vaccine in Gothenburg, Sweden, in the 1990s. A total of 495 children with itching nodules were patch tested with aluminium chloride hexahydrate 2% and an empty Finn Chamber®, 377 (76%) with positive reactions. When 241 of them were re‐tested some years later 186 (3 out of 4) had unexpectedly lost their patch test reactivity.
Aim
To investigate the long‐term prognosis of vaccine‐induced contact allergy to aluminium by a third patch test about 20 years after Patch test I.
Methods
Twenty individuals with positive and 11 with negative results in Patch test II were tested a third time with the same sensitisers as in in the first two tests. Three additional aluminium preparations were also tested.
Results
A total 15 out of 20 persons with positive results in the second test had lost their patch test reactivity. Two of 11 with negative tests had turned positive again. The addition of the preparations gave no conclusive results.
Conclusion
Contact allergy to aluminium caused by vaccination with aluminium‐adsorbed vaccines in childhood seems to fade away with time as measured by loss of patch test reactivity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology and Venereology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
- Department of Dermatology and Venereology, Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg, Sweden.
- General Practice/Family Medicine, School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
- Department of Paediatrics, Sahlgrenska University Hospital, Gothenburg, Sweden.
ORCID-Profile: Annica Inerot
Förderung
- ALF-Agreement
Zitieren
APA
Lidholm, A. G., Inerot, A., Gillstedt, M., Bergfors, E., & Trollfors, B. (2023). Long‐term prognosis of vaccine‐induced contact allergy to aluminium: Third patch‐test with additional test preparations. Contact Dermatitis. https://doi.org/10.1111/cod.14386
Vancouver
Lidholm AG, Inerot A, Gillstedt M, Bergfors E, Trollfors B. Long‐term prognosis of vaccine‐induced contact allergy to aluminium: Third patch‐test with additional test preparations. Contact Dermatitis. 2023. doi:10.1111/cod.14386
BibTeX
@article{Lidholm2023,
author = {Lidholm, Anette Gente and Inerot, Annica and Gillstedt, Martin and Bergfors, Elisabet and Trollfors, Birger},
title = {Long‐term prognosis of vaccine‐induced contact allergy to aluminium: Third patch‐test with additional test preparations},
journal = {Contact Dermatitis},
year = {2023},
doi = {10.1111/cod.14386}
}
EUVIMED